Read the recent Cancer Discovery review article by #AACRpan26 Conference Cochair Eileen M. O’Reilly, “Pancreatic Cancer: Translating Tumor Biology into Actionability.” buff.ly/PCng7ti #OpenAccess
Elizabeth McKenna
@elizsmckenna.bsky.social
Executive Editor of Cancer Discovery, published by AACR. Harvard BBS/Dana-Farber alum. Native New Yorker. Posts are my own. She/her https://aacrjournals.org/cancerdiscovery
From Cancer Discovery: Sevabertinib for HER2 Alterations in Lung Cancer doi.org/10.1158/2159...
Sevabertinib, a Reversible HER2 Inhibitor with Activity in Lung Cancer
Sevabertinib, a non-covalent inhibitor of the HER2 kinase, shows activity in preclinical cancer models with genomic activation of ERBB2 and for patients with HER2-mutant lung cancer.
doi.org
The October issue of Cancer Discovery @aacrjournals.bsky.social is now online! The cover features work showing that asynchronous evolution of epithelium and stroma differentiates precursor lesions from pancreatic cancer - read that and more: aacrjournals.org/cancerdiscov...
A YSM study published in Cancer Discovery suggests dietary #fat composition could be a modifiable risk factor for #pancreatic ductal adenocarcinoma (PDAC), a highly lethal form of #cancer. @aacrjournals.bsky.social medicine.yale.edu/publication-...
Read the study in Cancer Discovery: Diet-Induced Phospholipid Remodeling Dictates Ferroptosis Sensitivity and Tumorigenesis in the Pancreas doi.org/10.1158/2159...
Diet-Induced Phospholipid Remodeling Dictates Ferroptosis Sensitivity and Tumorigenesis in the Pancreas
AbstractHigh-fat diet (HFD) intake has been linked to an increased risk of pancreatic ductal adenocarcinoma (PDAC), a lethal and therapy-resistant cancer. However, whether and how specific dietary fat...
doi.org
A YSM study published in Cancer Discovery suggests dietary #fat composition could be a modifiable risk factor for #pancreatic ductal adenocarcinoma (PDAC), a highly lethal form of #cancer. @aacrjournals.bsky.social medicine.yale.edu/publication-...
The September issue of Cancer Discovery @aacrjournals.bsky.social is online! The cover features work by Shengtao Zhou, Linjie Zhao, et al. showing that mitochondrial complex I deficiency in NK cells compromises metabolic fitness & antitumor activity in GBM aacrjournals.org/cancerdiscov...
Lisa Situ, PhD, Associate Editor of Cancer Discovery, is attending the Cancer Grand Challenges Conference: Spatial Biology and would love to hear about your research! Connect with her to discuss publishing opportunities in the Journals. #CancerGrandChallenges
Michele Hartsough, PhD, Senior Editor of Cancer Discovery, is excited to meet with the community at the Cold Spring Harbor Laboratory Meeting: Mechanisms & Models of Cancer. If you have a question about the Journals or want to discuss your research, reach out to her at michele.hartsough@aacr.org.
Check out this Cancer Discovery article featured in the spotlight of this weekly digest 👇 First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts doi.org/10.1158/2159...
DC state essential for antitumor responses acir.org/weekly-dige... @mariakoufaki.bsky.social @cruk-mi.bsky.social @santiagozelenay.bsky.social
The August issue of Cancer Discovery @aacrjournals.bsky.social is online! The cover features work by Jihui Hao and colleagues showing senescent CAFs drive early-stage lymph node metastasis in PDAC via lactate-mediated metabolic-epigenetic rewiring - that and more aacrjournals.org/cancerdiscov... 👇
Now online in Cancer Discovery @aacrjournals.bsky.social: Follicular Lymphoma Transformation Is Characterized by Cytokine-associated Remodeling of Stromal and Macrophage Compartments doi.org/10.1158/2159...
Now online in Cancer Discovery @aacrjournals.bsky.social: Systematic Targeting of Protein Complexes with Molecular COUPLrs - by Diane Yang, Stefan Andrew Harry, Harrison Byron Chong, Neha Khandelwal, Edwin Zhang, John Iafrate, @liron1bar-peled.bsky.social, and colleagues doi.org/10.1158/2159...
Now online in Cancer Discovery @aacrjournals.bsky.social: Molecular and Structural Basis of Pan-Resistance to BTK Degraders and Inhibitors doi.org/10.1158/2159...
My postdoctoral work! If you are interested in degraders/PROTACs, check it out!
Excited to announce a new paper out today in Cancer Discovery @aacrjournals.bsky.social on clinical mechanisms of resistance to BTK degraders. Led by @quinnsievers.bsky.social and part of our ongoing collaboration with Meghan Thompson, Nurix Therapeutics & Justin Taylor (U. Miami):
Excited to announce a new paper out today in Cancer Discovery @aacrjournals.bsky.social on clinical mechanisms of resistance to BTK degraders. Led by @quinnsievers.bsky.social and part of our ongoing collaboration with Meghan Thompson, Nurix Therapeutics & Justin Taylor (U. Miami):
Now online in Cancer Discovery @aacrjournals.bsky.social: LPL-Positive Endothelial Cells Control T-cell Homing in Liver Metastasis - by Xiaowen Zhang, Mahak Singhal, @hellmutaugustin.bsky.social, and colleagues doi.org/10.1158/2159... @dkfz.bsky.social @uniheidelberg.bsky.social
Congratulations to Xiaowen Zhang for her spectacular publication in Cancer Discovery identifying a subpopulation of LPL-expressing intratumoral endothelial cells that decisively controls the anti-tumor immune response in liver metastases. See: aacrjournals.org/cancerdiscov...
Now in Cancer Discovery: two studies showing that CDK8 inhibitors act by trapping Mediator on chromatin & that cancers w/driver oncogenes acting as dosage-sensitive transcription factors (e.g. aRMS, Ewing sarcoma) are vulnerable to impairment of transcriptional regulatory complex dynamics:
In case you missed this Cancer Discovery paper in the news last week: First-in-Human Testing of a Mutant KRAS Vaccine for Pancreatic Cancer Interception in High-Risk Cohorts - by Daniel Haldar, Amanda Huff, Michael Goggins, Elizabeth Jaffee, Neeha Zaidi, and colleagues @aacrjournals.bsky.social
A vaccine to intercept pancreatic cancer in high-risk individuals was safe and elicited specific and durable immune responses, according to research published in the AACR journal Cancer Discovery. Learn more: www.aacr.org/about-the-aa...
Robert Kruger, PhD, Editorial Director, Publications and Senior Executive Editor, Cancer Discovery is attending #AACRrarecancers26 and would love to hear about your research. Connect with him to discuss publishing opportunities in the Journals.
Hear from cancer vaccine expert and Editor-in-Chief of Cancer Immunology Research Elizabeth M. Jaffee, MD, FAACR, on the latest breakthroughs, the clinical progress, and the path toward new effective vaccine-based strategies.
Beyond therapy, research on vaccines for pancreatic cancer is exploring their application for cancer interception. Learn more about this and other recent advances on the #AACRBlog:
Now in Cancer Discovery @aacrjournals.bsky.social: Impact of Vitamin D on the CRC Immune Microenvironment: A Randomized Clinical Trial of Preoperative Vitamin D Supplementation in Patients w/Stage I-III CRC - by Andressa Dias Costa, Jonathan Nowak, Kimmie Ng, et al. doi.org/10.1158/2159...
Now online in Cancer Discovery @aacrjournals.bsky.social: Germline CDK12 Variants in Aggressive Prostate Cancer - by Sofie Tolmeijer, Colin Pritchard, Alexander Wyatt, and colleagues doi.org/10.1158/2159...
The July issue of Cancer Discovery @aacrjournals.bsky.social is online! The cover features work by Jimin Min, Lisa Schweizer, Anirban Maitra, Andreas Mund et al. using AI-powered deep visual proteomics to reveal molecular transitions in pancreatic cancer - more here: aacrjournals.org/cancerdiscov...
AACR is deeply concerned that proposed OMB regulations would disrupt the process for awarding federal research grants, severely weakening a program that has supported American medical innovation for decades. Learn more: buff.ly/GLOGlW8 #UnitedByCancerResearch
buff.ly
It's been a pleasure to work with Dr. Vander Heiden so far and I look forward to the next era of Cancer Discovery under his leadership! Luis Diaz, Tali Lev, Lisa Situ, Robert Kruger, and I joined him for our first team meeting at #AACR26 (Michele Hartsough and I-Mei Siu were holding down the fort)
AACR is pleased to announce that Matthew Vander Heiden, MD, PhD, FAACR, has been appointed editor-in-chief of the AACR journal Cancer Discovery. He joins Luis A. Diaz, Jr., MD, FAACR, in guiding this premier publication. Learn more: www.aacr.org/about-the-aa... #AACRFellows @aacrjournals.bsky.social
Now in Cancer Discovery @aacrjournals.bsky.social: Tumor Microbial Burden Drives Immune Responses via Regulation of Interferon Signaling - by Haoyue Liu, Jeong-Hoon Jang, Fuduan Peng, Hajar Rajaei, @linghua-wang.bsky.social , Luis Diaz, Florencia McAllister, and colleagues doi.org/10.1158/2159...
Harmony Turk, PhD, Executive Editor of Cancer Research, is attending the 2026 @metastasisresearch.bsky.social Society Biennial Congress. If you have a question about the journals or are interested in discussing your research, reach out to her at harmony.turk@aacr.org. #MRS2026
Now in Cancer Discovery @aacrjournals.bsky.social: Spatial Multiomics Implicate Tpex-B cell Interaction in Tertiary Lymphoid Structures after Neoadjuvant Therapy - by Jingying Huang, Yahui Chen, Peng Deng, Qian Kong, Konglan Lin, Ruijun Tian, Yiwen Lu, Shicheng Su, et al. doi.org/10.1158/2159...